(Q36288938)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16231061%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

review article

1 reference

title

Development and application of replication-incompetent HSV-1-based vectors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16231061%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16231061%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Berto E

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16231061%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Bozac A

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16231061%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 October 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16231061%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16231061%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

12 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16231061%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

S98-102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16231061%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302623

8 January 2020

exact match

0 references

cites work

Replication-defective herpes simplex virus vectors for gene transfer in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

Identification of immediate early genes from herpes simplex virus that transactivate the virus thymidine kinase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

Rapid method for construction of recombinant HSV gene transfer vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

Preproenkephalin promoter yields region-specific and long-term expression in adult brain after direct in vivo gene transfer via a defective herpes simplex viral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

Progress in development of herpes simplex virus gene vectors for treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

Identification and characterization of a novel non-infectious herpes simplex virus-related particle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

Immobilized cobalt affinity chromatography provides a novel, efficient method for herpes simplex virus type 1 gene vector purification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

Effect of genetic background and culture conditions on the production of herpesvirus-based gene therapy vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

Evidence for a bidirectional element located downstream from the herpes simplex virus type 1 latency-associated promoter that increases its activity during latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

Gene therapy progress and prospects: Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

Protective effect of herpes simplex virus-mediated neurotrophin gene transfer in cisplatin neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

Protection from bacterial infection by a single vaccination with replication-deficient mutant herpes simplex virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

Modulation of mucosal and systemic immunity by enteric administration of nonreplicating herpes simplex virus expressing cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

Herpes simplex virus vectors elicit durable immune responses in the presence of preexisting host immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

Multi-modal combination gene therapy for malignant glioma using replication-defective HSV vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

Safety and biodistribution studies of an HSV multigene vector following intracranial delivery to non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

Treatment of rat gliosarcoma brain tumors by HSV-based multigene therapy combined with radiosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

Connexin 43-enhanced suicide gene therapy using herpesviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

Gene therapy using replication-defective herpes simplex virus vectors expressing nerve growth factor in a rat model of diabetic cystopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

HSV vector-mediated transduction and GDNF secretion from adipose cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

Herpes simplex virus inhibits host cell splicing, and regulatory protein ICP27 is required for this effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

7 January 2021

Purification of herpes simplex virus type 1 by density gradient centrifugation and estimation of the sedimentation coefficient of the virion.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

7 January 2021

The neurotrophic factor concept: a reexamination.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

7 January 2021

Vaccine potential of a herpes simplex virus type 1 mutant with an essential glycoprotein deleted

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

7 January 2021

Replication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302623

7 January 2021